Global Cord Blood (CORBF) Stock Price, News & Analysis

Company Overview

Global Cord Blood Corporation, traded on the New York Stock Exchange under the symbol CORBF, is a specialized provider of umbilical cord blood banking services. The company focuses on the collection, processing and long-term cryogenic storage of cord blood stem cells, which can be used for a variety of therapeutic and research applications. Its offerings include private family banking solutions as well as public and directed donation programs designed to support patients in need of hematopoietic stem cell transplants.

Headquartered in Hong Kong with principal operations in Japan, Global Cord Blood serves hospitals, obstetric clinics and research institutions across the Asia-Pacific region. The company operates state-of-the-art processing laboratories and storage facilities that comply with international quality and safety standards. In addition to its core preservation services, Global Cord Blood works closely with clinical and academic partners to facilitate clinical trials, regenerative medicine research and the development of novel cell-based therapies.

Founded in the early 2000s, Global Cord Blood has built a substantial repository of cord blood units, supporting both patient transplantation needs and ongoing scientific studies. The company’s management team comprises professionals with extensive backgrounds in healthcare, biotechnology and regulatory affairs, ensuring that its operations adhere to best practices in stem cell handling and biobanking. Through strategic collaborations and continuous investment in infrastructure, Global Cord Blood aims to advance the field of cellular therapies and expand access to life-saving stem cell treatments.

Key Stats

• Today's Range: $0.95 to $0.95
• 50-Day Range: $0.95 to $1.10
• 52-Week Range: $0.20 to $1.75
• Volume: 1,006 shs
• Average Volume: 373 shs
• Market Capitalization: $115.53 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

CORBF Stock Analysis - Frequently Asked Questions

How have CORBF shares performed this year?

Global Cord Blood's stock was trading at $0.95 on January 1st, 2026. Since then, CORBF stock has increased by 0.1% and is now trading at $0.9505.

How do I buy shares of Global Cord Blood?

Shares of CORBF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

• Today: 5/06/2026
• Fiscal Year End: 3/31/2027

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Miscellaneous health & allied services, not elsewhere classified
• Sub-Industry: Healthcare
• Current Symbol: OTCMKTS:CORBF
• Previous Symbol: NYSE:CORBF
• CIK: 1467808
• Web: www.globalcordbloodcorp.com
• Phone: 852-3605-8180
• Fax: 852-3605-8181
• Employees: 1,200
• Year Founded: 2003

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 121,550,000
• Free Float: 120,943,000
• Market Cap: $115.53 million
• Optionable: Not Optionable
• Beta: -0.80